NOTES:
- Several NDC lists and medication tables are used for multiple products. The NDC lists reference the table names used in the Technical Specifications for Health Plans and Technical Specifications for Physician Measurement. When a list/table applies to additional products, it is noted below.
- Changes have been made to some tables subsequent to the release of the technical specifications and are described in the Medication Table word documents.
- Other NDC codes that match generic name, strength/dose and route indicated in the posted NDC lists may be mapped for use in HEDIS reporting. Please refer to the general guidelines for Mapping Proprietary or Other Codes section for additional information.
- section for additional information.
HEDIS 2013 NDC LISTS
| ||
HEDIS 2013 NDC Lists and Updated Medication Tables (.zip)
Updated November 2, 2012 |
2013 NDC Lists
|
Medication Table
|
Adherence to Antipsychotic Medications for Individuals with Schizophrenia (SAA)
| ||
Table SAA-A: Antipsychotic MedicationsDA
|
No changes. Refer to the table in the publication.
| |
| Annual Monitoring for Patients on Persistent Medications (MPM) | ||
Table MPM-B: Drugs to Identify Members on Digoxin
Note: This table is also used for: Accountable Care Organizations: Table AMPM-B. |
No changes. Refer to the table in the publication.
| |
Table MPM-C: Drugs to Identify Members on Diuretics
Note: This table is also used for:
Accountable Care Organizations: Table AMPM-C. |
No changes. Refer to the table in the publication.
| |
Table MPM-D: Drugs to Identify Members on Anticonvulsants
Note: This table is also used for:
Accountable Care Organizations: Table AMPM-D. |
No changes. Refer to the table in the publication.
| |
| Antibiotic Utilization (ABX) | ||
| Table ABX-A: Antibiotic Medications | ||
| Table ABX-B: Antibiotic of Concern by NCQA Drug Class | ||
| Table ABX-C: All Other Antibiotics by NCQA Drug Class | ||
| Antidepressant Medications Management (AMM) | ||
Table AMM-C: Antidepressant Medications
Note: This table is also used for:
Accountable Care Organizations: Table AAMM-C |
No changes. Refer to the table in the publication.
| |
| Appropriate Treatment for Children with Pharyngitis (CWP) | ||
Table CWP-C: Antibiotic Medications
Note: This table is also used for:
Accountable Care Organizations: Table ACWP-C. | ||
| Asthma Medication Ratio (AMR) | ||
| Table AMR-A: Asthma Controller and Reliever Medications | ||
| Avoidance of Antibiotic Treatment for Adults with Acute Bronchitis (AAB) | ||
Table AAB-D: : Antibiotic Medications
Note: This table is also used for:
Accountable Care Organizations: Table AAAB-D. | ||
| Chlamydia Screening in Women (CHL) | ||
Table CHL-A: Prescriptions to Identify Contraceptives
Note: This table is also used for:
Accountable Care Organizations: Table ACHL-A. |
No changes. Refer to the table in the publication.
| |
Table CHL-E: Medication to Identify Exclusions
Note: This table is also used for:
Accountable Care Organizations:Table ACHL-D. |
No changes. Refer to the table in the publication.
| |
| Comprehensive Diabetes Care (CDC) | ||
Table CDC-A: Prescriptions to Identify Members with Diabetes
Note: This table is also used for:
Accountable Care Organizations: Table ACDC-A; Disease Management: Table DCDC-A. | ||
Table CDC-L: ACE Inhibitors/ARBs
Note: This table is also used for:
Accountable Care Organizations: Table ACDC-M; Disease Management: Table DCDC-P. |
No changes. Refer to the table in the publication.
| |
| Comprehensive Ischemic Vascular Disease Care (IVD) | ||
Table IVD-E: Oral Anti-Platelet Therapies
Note: This table is only applicable to the Technical Specifications for Physician Measurement.
|
No changes. Refer to the table in the publication.
| |
| Management of People with Ischemic Vascular Disease (DIVD) | ||
Table DIVD-G: Aspirin or Other Antithrombotic Medications
Note: This table is only applicable to the Technical Specifications for Disease Management.
|
No changes. Refer to the table in the publication.
| |
| Diabetes Screening for People With Schizophrenia or Bipolar Who Are Using Antipsychotic Medications (SSD) | ||
| Table SSD-D: Antipsychotic Medications |
No changes. Refer to the table in the publication.
| |
| Disease Modifying Anti-Rheumatic Drug Therapy (ART) | ||
Table ART-C: DMARDs
Note: This table is also used for:
Accountable Care Organizations: Table AART-D. |
No changes. Refer to the table in the publication.
| |
| Follow-Up Care for Children Prescribed ADHD Medication (ADD) | ||
Table ADD-A: ADHD Medications
Note: This table is also used for:
Accountable Care Organizations: Table AADD-A. |
No changes. Refer to the table in the publication.
| |
| Osteoporosis Management in Women Who had a Fracture (OMW) | ||
Table OMW-C: FDA-Approved Osteoporosis Therapies
Note: This table is also used for:
Accountable Care Organizations: Table AOMW-D. |
No changes. Refer to the table in the publication.
| |
| Persistence of BB Treatment After a Heart Attack (PBH) | ||
Table PBH-B: Beta-Blocker Medications
Note: This table is also used for:
Disease Management: Table DPBH-B. |
No changes. Refer to the table in the publication.
| |
Table PBH-D: Medications to Identify Exclusion (History of Asthma)
Note: This table is also used for:
Disease Management: Table DPBH-D. |
No changes. Refer to the table in the publication.
| |
| Pharmacotherapy Management of COPD Exacerbation (PCE) | ||
| Table PCE-C: Systemic Corticosteroids |
No changes. Refer to the table in the publication.
| |
| Table PCE-D: Bronchodilators | ||
| Potentially Harmful Drug-Disease Interactions in the Elderly (DDE) | ||
Table DDE-C: Tricyclic Antidepressants
Note: This table is also used for:
Accountable Care Organizations: Table ADDE-C. |
No changes. Refer to the table in the publication.
| |
Table DDE-D: Antipsychotics and Sleep Agents
Note: This table is also used for:
Accountable Care Organizations: Table ADDE-D. |
No changes. Refer to the table in the publication.
| |
Table DDE-F: Medications for Dementia
Note: This table is also used for:
Accountable Care Organizations: Table ADDE-F. |
No changes. Refer to the table in the publication.
| |
Table DDE-G: Anticholingeric Agents
Note: This table is also used for:
Accountable Care Organizations: Table ADDE-G. | ||
Table DDE-I: NSAIDs and Cox-2 Selective NSAIDs
Note: This table is also used for:
Accountable Care Organizations: Table ADDE-I. |
No changes. Refer to the table in the publication.
| |
| Use of Appropriate Medications for People with Asthma (ASM) | ||
Table ASM-C: Asthma Medications
Note: This table is also used for:
Accountable Care Organizations: Table AASM-C; Disease Management: Table DASM-C. | ||
Table ASM-D: Asthma Controller Medications
Note: This table is also used for:
Accountable Care Organizations: Table AASM:E; Disease Management: Table DASM-E. | ||
| Use of High-Risk Medications in the Elderly (DAE) | ||
Table Table DAE-A: High-Risk Medications (Updated November 2, 2012)
Note: This table is also used for:
Accountable Care Organizations: Table ADAE-A. | ||
Table DAE-B: High-Risk Medications with Days Supply Criteria
Note: This table is also used for:
Accountable Care Organizations: Table ADAE-B. |
No changes. Refer to the table in the publication.
| |
Table DAE-C: High-Risk Medications with Average Daily Dose Criteria
Note: This table is also used for:
Accountable Care Organizations: Table ADAE-C. |
No changes. Refer to the table in the publication.
| |
0 التعليقات:
إرسال تعليق